QS Investors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$316,000
+4.3%
3,1750.0%0.00%0.0%
Q3 2020$303,000
-79.7%
3,175
-76.2%
0.00%
-81.0%
Q2 2020$1,495,000
+53.8%
13,3650.0%0.02%
+40.0%
Q1 2020$972,000
-30.2%
13,365
+0.6%
0.02%
+7.1%
Q4 2019$1,392,000
+4.4%
13,290
-0.7%
0.01%
-6.7%
Q3 2019$1,333,000
-12.8%
13,3900.0%0.02%
-6.2%
Q2 2019$1,529,000
-11.3%
13,390
-2.3%
0.02%
-15.8%
Q1 2019$1,724,000
+2398.6%
13,710
+2625.6%
0.02%
+1800.0%
Q4 2018$69,000
-50.0%
5030.0%0.00%0.0%
Q3 2018$138,000
+32.7%
5030.0%0.00%0.0%
Q2 2018$104,000
+25.3%
5030.0%0.00%0.0%
Q1 2018$83,000
+20.3%
5030.0%0.00%0.0%
Q4 2017$69,000
+1.5%
5030.0%0.00%0.0%
Q3 2017$68,000
+11.5%
5030.0%0.00%0.0%
Q2 2017$61,000
+15.1%
5030.0%0.00%
Q1 2017$53,000
+5200.0%
503
+16666.7%
0.00%
Q4 2016$1,0000.0%30.0%0.00%
Q3 2016$1,0000.0%3
+50.0%
0.00%
Q2 2016$1,0000.0%2
-60.0%
0.00%
Q1 2016$1,0000.0%5
+150.0%
0.00%
Q4 2015$1,00020.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders